Related Experiment Videos

Effect of the genetic background and specific mutation on adenylate cyclase activity in obesity syndromes

N Bégin-Heick1, D L Coleman

  • 1Department of Biochemistry, University of Ottawa, Canada.

Insights

Genetic obesity in mice involves distinct mechanisms affecting adenylate cyclase activity. Studies reveal differences in how obese (ob/ob) and diabetic (db/db) mouse models respond to inhibitory and stimulatory signaling pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Obesity is linked to altered cellular signaling pathways.
  • Adenylate cyclase is a key enzyme in cellular signal transduction.
  • Previous studies identified defects in inhibitory modulation in obese (ob/ob) mice.

Purpose of the Study:

  • To investigate adenylate cyclase activity in adipocyte membranes of genetically obese mouse models.
  • To compare the modulation of adenylate cyclase by guanine nucleotides and isoproterenol in ob/ob and db/db mice.
  • To determine if the inhibitory modulation defect in ob/ob mice is also present in db/db mice.

Main Methods:

  • Assessed adenylate cyclase activity in adipocyte membranes.
  • Utilized guanine nucleotides (GTP) and isoproterenol for modulation studies.
  • Administered pertussis toxin to assess G-protein involvement.

Main Results:

  • Adipocyte adenylate cyclase in both ob/ob and db/db mice showed resistance to isoproterenol activation.
  • Guanosine triphosphate (GTP) response differed: an inhibitory phase was observed in db/db but not ob/ob membranes.
  • Pertussis toxin attenuated GTP's inhibitory effect and stimulated cyclase activity in db/db mice, but not ob/ob mice.

Conclusions:

  • The ob/ob and db/db mouse models exhibit distinct mechanisms affecting adenylate cyclase activity.
  • These findings highlight differential impacts of genetic mutations on cellular signaling in obesity and diabetes.

Related Concept Videos